🏢
🌐 Entity
Bempedoic acid
Redirected from Nexletol
📊 Rating
1 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Intellectual Property (1)
- Pharmaceutical Industry (1)
- Legal Settlements (1)
🏷️ Keywords
Esperion Therapeutics (1) · Alkem Laboratories (1) · Cholesterol drugs (1) · Patent dispute (1) · Bempedoic acid (1) · Pharmaceutical litigation (1) · Cardiovascular medication (1) · Generic drugs (1)
📖 Key Information
Bempedoic acid, sold under the brand name Nexletol among others, is a medication for the treatment of hypercholesterolemia (high blood cholesterol levels).
The most common side effects include hyperuricemia (high blood levels of uric acid), pain in arms or legs, and anemia (low red blood cell counts).
Bempedoic acid blocks an enzyme in the liver called adenosine triphosphate-citrate lyase, which is involved in making cholesterol.
📰 Related News (1)
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside Bempedoic acid:
-
🏢
Esperion Therapeutics · 1 shared articles
-
🏢
Alkem Laboratories · 1 shared articles
-
New York City · 1 shared articles -
Patent infringement · 1 shared articles